Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region. - Shemesh CS; Chan P; Shao H; Xu DZ; Combs D; Vadhavkar S; Bruno R; Wu B (Liver cancer, 2021)